Follicular lymphoma in the United States: first report of the national LymphoCare study (Q37334742)

19 August 2017

Follicular lymphoma in the United States: first report of the national LymphoCare study (English)

1 reference

19 August 2017

United States of America

0 references

1 reference

8

John D Hainsworth

1 reference

19 August 2017

10

Julie M Vose

1 reference

19 August 2017

11

Andrew D Zelenetz

1 reference

19 August 2017

Jonathan W Friedberg

1

1 reference

19 August 2017

Michael D Taylor

2

1 reference

19 August 2017

James R Cerhan

3

1 reference

19 August 2017

Christopher R Flowers

4

1 reference

19 August 2017

Hildy Dillon

5

1 reference

19 August 2017

Charles M Farber

6

1 reference

19 August 2017

Eric S Rogers

7

1 reference

19 August 2017

Elaine K Wong

9

1 reference

19 August 2017

Brian K Link

12

1 reference

19 August 2017

language of work or name

English

0 references

publication date

9 February 2009

1 reference

Journal of Clinical Oncology

19 August 2017

1 reference

19 August 2017

27

1 reference

19 August 2017

8

1 reference

19 August 2017

1202-1208

1 reference

19 August 2017

Cancer statistics, 2007

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738614

New treatment options have changed the survival of patients with follicular lymphoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738614

Radiation therapy for localized low-grade non-Hodgkin's lymphomas

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738614

Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738614

Impact of individual physicians on enrollment of patients into clinical trials

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738614

Follicular non-Hodgkin's lymphoma: the role of radiation therapy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738614

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738614

Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738614

Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738614

Survival after progression in patients with follicular lymphoma: analysis of prognostic factors

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738614

Variations in chemotherapy and radiation therapy in a large nationwide and community-based cohort of elderly patients with non-Hodgkin lymphoma

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738614

Improved survival of follicular lymphoma patients in the United States

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738614

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738614

Follicular lymphoma international prognostic index.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738614

Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738614

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2738614

Oncologist's role critical to clinical trial enrollment

2 September 2018

1 reference

12 December 2020

Clinical trial enrollment of rural patients with cancer

1 reference

12 December 2020

Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy

1 reference

12 December 2020

Barriers to clinical trial enrollment: are state mandates the solution?

1 reference

12 December 2020

The natural history of initially untreated low-grade non-Hodgkin's lymphomas

1 reference

12 December 2020

Is the International Prognostic Index for Aggressive Lymphoma patients useful for follicular lymphoma patients?

1 reference

12 December 2020

Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma

1 reference

12 December 2020

Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project

1 reference

12 December 2020

Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed follicular lymphoma

1 reference

12 December 2020

Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy

1 reference

12 December 2020

Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology

1 reference

12 December 2020

Improvement of overall and failure-free survival in stage IV follicular lymphoma: 25 years of treatment experience at The University of Texas M.D. Anderson Cancer Center

1 reference

12 December 2020

Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience

1 reference

12 December 2020

The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin

1 reference

12 December 2020

Potential long-term toxicities should influence the choice of therapy for indolent non-Hodgkin's lymphoma

1 reference

12 December 2020

Is the follicular lymphoma international prognostic index better than the international prognostic index to identify high-risk follicular lymphoma patients?

1 reference

12 December 2020

How I treat indolent lymphoma

1 reference

12 December 2020

Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma

1 reference

12 December 2020

Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up

1 reference

12 December 2020

Identifiers

DOI

10.1200/JCO.2008.18.1495

1 reference

19 August 2017

1 reference

19 August 2017

PubMed publication ID

19204203

1 reference